A large number of OTC drugs, health insurance is not reimbursed.

At this stage, although more than 500 OTC drugs have not been transferred out of the Medicare Drug Catalog, in the long run, this proportion will still shrink.
OTC drugs, in principle, no longer add according to the latest news of the National Health Insurance Administration, after five large-scale medical insurance catalog adjustment, the current number of national health insurance catalog drugs has increased from 1535 to 2709.
preliminary statistics, the 2019 version of the catalog has more than 500 over-the-counter drugs, accounting for a higher proportion of the health insurance directory.
October 10, the National Health Insurance Administration responded to the NPC representative's "recommendations on maintaining the original medical insurance management policy for over-the-counter drugs at this stage" and "recommendations on maintaining the OTC drug health insurance policy".
Referment makes it clear that over-the-counter drugs already in the National List of Essential Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drugs (the "Medicare Drug Catalog") may continue to be retained as eligible and, like other medicines, managed in accordance with the current medical insurance policy.
also noted that over-the-counter medicines were generally not reimbursed internationally.
, taking into account the affordability of basic medical insurance and other factors, clearly stipulates that the "health insurance drug catalog" in principle will not add OTC drugs.
there will still be OTC drugs, which will be called out of the catalogue, but the reply also emphasizes that over-the-counter drugs that fall within the scope of the transferable varieties stipulated in Article 9 of the Interim Measures for the Administration of Drug Use in Basic Medical Insurance (hereinafter referred to as the Measures) shall be withdrawn according to the procedure.
In accordance with Article 9 of the Measures, if one of the following five categories exists, the List of Medical Insurance Drugs shall be directly called out after expert evaluation: 1. Drugs that have been revoked, revoked or cancelled by the drug regulatory authorities; drugs; 3, taking into account clinical value, adverse reactions, drug economy and other factors, drugs assessed to be more risky than the benefits; 4, drugs entered the Drug Catalog by means of fraud and other illegal means; 5, other circumstances that should be directly transferred out as prescribed by the State.
two points, the "Health Insurance Drug Catalog" in principle will not add OTC drugs, but according to the actual situation, there will be the possibility of being transferred out.
simple understanding is that OTC drugs in the Medicare Drug Catalog are only doesn't come in.
A large number of OTC drugs, can no refore be reimbursed, the State Health Insurance Administration also stressed that the next step will be to implement the "CPC Central Committee and the State Council on deepening the reform of the medical security system", further focus on the needs of disease prevention and treatment, to ensure the basic drug demand of insured personnel, establish a dynamic adjustment mechanism for medical insurance drug use, improve the basic medical insurance drug scientific, fine management level.
the request of this opinion, improve the dynamic adjustment mechanism of the medical insurance catalogue.
to reasonably divide the central and local catalogues to adjust their duties and authority, all regions shall not make their own catalogues or adjust the scope of limited payment for medical insurance drugs, and gradually realize the basic unification of the scope of medical insurance use throughout the country.
At the same time, the State Health Insurance Administration and other three departments issued "on doing a good job in 2020 urban and rural residents of basic medical security notice" also clearly, the formulation of three-year digestion plan for the provinces to add varieties, by the end of June 2020 the national key monitoring varieties out of the catalogue and complete 40% of the provincial supplement varieties digestion.
the current situation, all over the digestion, there are a large number of OTC drugs have been kicked out of the catalog.
the rules, these drugs, the health insurance fund will not be reimbursed.
October 10, Qinghai Provincial Health Insurance Bureau issued a notice that, in accordance with the relevant documents of the State Health Insurance Bureau, the Ministry of Human Resources and Social Affairs, the original provincial drug catalogue in accordance with the provisions of the addition of Class B drugs, should be gradually digested within three years.
study, it was decided that the 227 additional drugs in our province should be transferred out of qinghai Province's list of basic medical insurance, work injury insurance and maternity insurance drugs (2019 edition).
In accordance with the requirements of Qinghai Province, in 2020, transferred out of the national key monitoring drugs and the previous year's drug procurement platform in our province did not recruit the use of drugs, a total of 129 varieties, from January 1, 2021 to stop medical insurance, work injury insurance payment, involving children's ammonia jaundip granules, compound children retreat thrombosis, dragon bile liver oral solution and many other OTC drugs.
2022, the remaining 98 varieties will be transferred, and from January 1, 2023, medical insurance and work-related injury insurance will be discontinued, involving a number of OTC drugs, such as dashan sorghum pills, 10 full supplement pills, and detoxifying particles.
the Beijing Municipal Medical Insurance Bureau, as of October 1, 2020, the first batch of transfer drugs will no longer be included in the city's basic medical insurance, work injury insurance and maternity insurance payments.
The first batch of non-state medical insurance drug varieties transferred out of Beijing totaled 224, of which 136 were Western medicine species, 88 chinese medicine varieties, involving a number of OTC drugs such as mulberry cold oral fluid, cold heat-regression particles.
.